Volume | 3,972,505 |
|
|||||
News | - | ||||||
Day High | 9.97 | Low High |
|||||
Day Low | 9.57 |
Etf Name | Etf Symbol | Market | Stock Type |
---|---|---|---|
Advisorshares Pure Us Cannabis Etf | MSOS | AMEX | Exchange Traded Fund |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
9.97 | 9.57 | 9.97 | 9.78 |
Trades | Etfs Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
10,163 | 3,972,505 | 9.78 | 38,832,338 | - | 4.78 - 11.365 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
10:08:04 | 200 | 9.63 | USD |
Advisorshares Pure Us Ca... (MSOS) Options Flow Summary
Advisorshares Pure Us Cannabis Etf Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.13B | - | - | - | 12.38 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Advisorshares Pure Us Ca...
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
MSOS Historical
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 9.45 | 10.50 | 8.90 | 9.64 | 11,757,193 | 0.18 | 1.90% |
1 Month | 9.02 | 11.365 | 8.32 | 9.67 | 12,569,422 | 0.61 | 6.76% |
3 Months | 9.23 | 11.365 | 7.30 | 9.40 | 10,454,895 | 0.40 | 4.33% |
6 Months | 6.47 | 11.365 | 5.99 | 8.91 | 8,190,923 | 3.16 | 48.84% |
1 Year | 5.50 | 11.365 | 4.78 | 8.07 | 6,725,528 | 4.13 | 75.09% |
3 Years | 40.63 | 42.059 | 4.78 | 10.45 | 3,269,605 | -31.00 | -76.30% |
5 Years | 24.90 | 55.91 | 4.78 | 11.90 | 2,772,305 | -15.27 | -61.33% |
The investment seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology and life sciences industry group within the health care sector. The fund is non-diversified. |